- Home
- JSPR vs MASS Comparison
JSPR vs MASS Comparison
Compare JSPR & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- MASS
- Stock Information
- Founded
- JSPR 2018
- MASS 2012
- Country
- JSPR United States
- MASS United States
- Employees
- JSPR N/A
- MASS N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- MASS Medical/Dental Instruments
- Sector
- JSPR Health Care
- MASS Health Care
- Exchange
- JSPR Nasdaq
- MASS Nasdaq
- Market Cap
- JSPR 82.4M
- MASS 84.3M
- IPO Year
- JSPR N/A
- MASS 2020
- Fundamental
- Price
- JSPR $5.96
- MASS $2.53
- Analyst Decision
- JSPR Strong Buy
- MASS Buy
- Analyst Count
- JSPR 12
- MASS 3
- Target Price
- JSPR $64.44
- MASS $5.33
- AVG Volume (30 Days)
- JSPR 452.6K
- MASS 298.0K
- Earning Date
- JSPR 03-07-2025
- MASS 03-04-2025
- Dividend Yield
- JSPR N/A
- MASS N/A
- EPS Growth
- JSPR N/A
- MASS N/A
- EPS
- JSPR N/A
- MASS N/A
- Revenue
- JSPR N/A
- MASS $55,162,000.00
- Revenue This Year
- JSPR N/A
- MASS $15.31
- Revenue Next Year
- JSPR N/A
- MASS $16.10
- P/E Ratio
- JSPR N/A
- MASS N/A
- Revenue Growth
- JSPR N/A
- MASS 16.08
- 52 Week Low
- JSPR $4.55
- MASS $1.81
- 52 Week High
- JSPR $31.01
- MASS $7.91
- Technical
- Relative Strength Index (RSI)
- JSPR 34.64
- MASS 49.72
- Support Level
- JSPR $4.55
- MASS $2.29
- Resistance Level
- JSPR $6.55
- MASS $3.05
- Average True Range (ATR)
- JSPR 0.53
- MASS 0.25
- MACD
- JSPR 0.49
- MASS 0.01
- Stochastic Oscillator
- JSPR 56.18
- MASS 33.33
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.